▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3582 by analyst upside · 2026-09-26
THC
Tenet Healthcare Corporation
Healthcare · Market Cap $21B · P/E 10.0x
ANALYST PRICE TARGET
+9.6%
implied upside to consensus target
Current Price $259.71
Consensus Target $284.64
Bull Target $315.0
Bear Target $260.0
Analysts Covering 22
ANALYST CONSENSUS - BUY
Strong Buy
5
Buy
13
Hold
4
Sell
0
52-Week Low $157.58
52-Week High $283.05
YTD Return +30.2%
FUNDAMENTALS
Market Cap $21B
P/E Ratio (TTM) 10.0x
Forward P/E 12.3x
EPS (TTM) $25.88
PEG Ratio 1.73
Dividend Yield N/A
Revenue (TTM) $21.8B
Profit Margin 10.3%
52-WEEK RANGE
52-Week Low $157.58
52-Week High $283.05
Current Price $259.71
Bear Target $260.0
Bull Target $315.0
● Now $259.71 ● Target $284.64
TRADING DATA
Avg Volume 1.1M
YTD Return +30.2%
Analyst Count 22
Consensus Buy
Upside to Target +9.6%
Last Updated 2026-09-26

ANALYST SUMMARY

Tenet Healthcare Corporation (THC) is currently trading at $259.71 with a Wall Street consensus price target of $284.64, implying potential upside of 9.6% over the next 12 months. 22 analysts currently cover THC, with a consensus rating of Buy - 82% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $315.0, while the most cautious has a target of $260.0.

THC operates in the Healthcare sector with a market capitalisation of $21B. The stock is up 30.2% year-to-date and is currently trading near the upper end of its 52-week range of $157.58 – $283.05.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for THC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BMO Capital ● Initiated
Market Perform 2026-09-23 Building track record
Leerink Partners - Reiterated
Outperform → Outperform 2026-09-18 29% win rate (7 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-08-03 Building track record
Truist Securities - Reiterated
Buy → Buy 2026-07-28 Building track record
Baird - Reiterated
Neutral → Neutral 2026-07-28 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-07-28 62% win rate (8 calls)
UBS - Reiterated
Buy → Buy 2026-07-27 33% win rate (6 calls)
TD Cowen - Reiterated
Buy → Buy 2026-07-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
72
out of 100
Coverage depth
24/30
Consensus clarity
26/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →